Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,937 DKK | +0.31% | +0.55% | -10.12% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
Sales 2024 * | 19.8B 2.88B | Sales 2025 * | 23.62B 3.44B | Capitalization | 125B 18.17B |
---|---|---|---|---|---|
Net income 2024 * | 4.67B 680M | Net income 2025 * | 6.61B 962M | EV / Sales 2024 * | 5 x |
Net cash position 2024 * | 25.9B 3.77B | Net cash position 2025 * | 32.35B 4.71B | EV / Sales 2025 * | 3.92 x |
P/E ratio 2024 * |
28.5
x | P/E ratio 2025 * |
20.5
x | Employees | 2,286 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Genmab A/S
1 day | +0.31% | ||
1 week | +0.55% | ||
1 month | -1.45% | ||
3 months | -3.97% | ||
6 months | -10.24% | ||
Current year | -10.12% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Director/Board Member | 73 | 03-10-31 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 200 M€ | +16.70% | ||
1.28% | 48 M€ | +9.22% | ||
1.01% | 85 M€ | -0.54% | ||
0.75% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,937 | +0.31% | 711,147 |
24-05-30 | 1,931 | +0.55% | 105,877 |
24-05-29 | 1,920 | -0.72% | 116,926 |
24-05-28 | 1,934 | -1.05% | 118,736 |
24-05-27 | 1,955 | +1.48% | 124,780 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 18.16B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B | |
+7.26% | 7.75B |
- Stock Market
- Equities
- GMAB Stock